20% of OST-HER2 treated dogs survived 2-year vs. 1% in control group (p = 0.00995)

Over 15,000 dogs per year diagnosed with osteosarcoma

Company expects to submit U.S. Department of Agriculture meeting request to gain alignment on regulatory path towards conditional approval in the third quarter of 2026

OS Therapies reiterates plan to distribute OS Animal Health shares to shareholders

OS Animal Health plans crowdfunding to expand shareholder base to meet U.S. national exchange initial listing standards, with indications of interest now being received